Celec P., Ostatnikova D., Hodosy J. On the effects of testosterone on brain behavioral functions. Front. Neurosci. 2015. 9. 12.
Dedov I.I., Melnichenko G.A., Rozhivanov R.V., Kurbatov D.G. Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients. Problemy endokrinologii = Problems of endocrinology. 2015. 61. (5). 60-71. [In Russian].
Epanchintseva E.A., Selyatitskaya V.G., Sheina Y.I. Ejaculate parameters in patients with abdominal obesity. Andrologiya i genital'naya khirurgiya = Andrology and Genital Surgery. 2015. 16. (1). 88-93. [In Russian].
Fugh-Berman A., Scialli A.R. Testosterone and sexual function. Curr. Opin. Urol. 2017. 27. (6). 516-518.
Iskanderov B.G. Affective disorders and heart rhythm disturbances. Penza: 2011.168 p. [In Russian].
Ivanchenko D.N., Dorofeeva N.P., Shlyk S.V. Depressive disorders in patients with cardiovascular disease: determining the prognosis. Meditsinskiy vestnik Yuga Rossii = Medical Herald of the South of Russia. 2016. (1).28-32. [In Russian].
Khera M. Patients with testosterone deficiency syndrome and depression. Arch. Esp. Urol. 2013. 66. (7). 729-736.
Kim E.Y., Kim S.H., Ha K., Lee H.J., Yoon D.H., Ahn Y.M. Depression trajectories and the association with metabolic adversities among the middle-aged adults. J. Affect. Disord. 2015. 188. 14-21.
Novikova E., Selyatitskaya V., Mitrofanov I., Pinkhasov B., Karapetyan A. Association of erectile dysfunction and hypogonadism with metabolic syndrome in men with lower urinary tract symptoms of younger and older age groups. Adv. Sex. Med. 2014. 4. 55-64.
Paltsev M.A., Kvetnoy I.M., Polyakova V.O., Kvetnaiya T.V., Trofimov A.V. Neuroimmunoendocrine mechanisms of aging. Adv. Gerontol. 2011. 1. (1). 28–38.
Patent № 2387374 RF. Method for determining the biological age of a person and the rate of aging / Gorelkin A.G., Pinkhasov B.B.; published 27.04.2010. [In Russian].
Penninx B.W.J.H., Milaneschi Y., Lamers F., Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013. 11. 129.
Shabsigh R., Arver S., Channer K.S., Eardley I., Fabbri A., Gooren L., Heufelder A., Jones H., Meryn S., Zitzmann M. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int. J. Clin. Pract. 2008. 62. (5). 791-798.
Soboleva N.P., Rudnev S.G., Nikolayev D.V., Eryukova T.A., Kolesnikov V.A., Mel'nichenko O.A., Ponomareva E.G., Starunova O.A., Sterlikov S.A. The bio-impedance screening of population in health centers: prevalence of surplus body mass and obesity. Rossiyskiy meditsinskiy zhurnal = Russian Medical Journal. 2014. (4). 4-13. [In Russian].
Suija K., Kerkela M., Rajala U., Jokelainen J., Laakso M., Harkonen P., Keinanen-Kiukaanniemi S., Timonen M. The association between erectile dysfunction, depressive symptoms and testosterone levels among middle-aged men. Scand. J. Public Health. 2014. 42. (7). 677-682.
Uzbekov M.G., Maksimova N.M. Monoamine-hormonal interactions in the pathogenesis of anxious depression. Zhurnal nevrologii i psikhiatrii imeni Sergeya Sergeevicha Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2015. 1. (2). 52-55. [In Russian].
Westley C.J., Amdur R.L., Irwig M.S. High rates of depression and depressive symptoms among men referred for borderline testosterone levels. J. Sex. Med. 2015. 12. (8). 1753-1760.
Yassin A.A., Nettleship J.E., Salman M., Almehmadi Y. Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction. Andrologia. 2017.49.(4).e12634.